Replimune REPL
NASDAQ REPL
$23.28 +1.02 (+4.58%)
At close: Nov 10, 2026 · 4:00 PM EST

Replimune (REPL) Payables (2018 - 2026)

Updated

Replimune (REPL) recorded Payables of $5.96 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 6.9% from $6.4 million a year earlier but up 39.8% from the prior quarter.

Analysis

Replimune (REPL) Payables (2018 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Replimune reported Payables of $6.67 million, down 46.5% from FY2025.

  • Annual Payables has a five-year compound annual growth rate of 23.2% (FY2021 to FY2026).
  • Across earlier fiscal years, Payables came in at $12.46 million in FY2025 (+383.4%), $2.58 million in FY2024 (-51.9%), $5.36 million in FY2023 (+43.7%) and $3.73 million in FY2022 (+58.5%).
  • Quarterly Payables has ranged from $864,000 in fiscal Q1 2025 to $15.48 million in fiscal Q1 2026 over the past five years.
  • On a year-over-year basis, Payables has declined for five consecutive quarters, with growth averaging 42.3% over the last seven quarters.
  • Peak year-over-year performance for Payables in the last five years was growth of 383.4% in fiscal Q4 2025, against a decline of 82.3% in fiscal Q1 2025 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $4.26 million (Q1 2027), $6.67 million (Q4 2026) and $5.65 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 18.17 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 34.43 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 7.17 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 22.89 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 934.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 4.07 Bn
10 Replimune 2.40 Bn 1.35 Bn - 5.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.96 Mn
Jun 30, 2026 4.26 Mn
Mar 31, 2026 6.67 Mn
Dec 31, 2025 5.65 Mn
Sep 30, 2025 6.40 Mn
Jun 30, 2025 15.48 Mn
Mar 31, 2025 12.46 Mn
Dec 31, 2024 7.19 Mn
Sep 30, 2024 8.41 Mn
Jun 30, 2024 864,000.00
Mar 31, 2024 2.58 Mn
Dec 31, 2023 3.90 Mn
Sep 30, 2023 4.37 Mn
Jun 30, 2023 4.88 Mn
Mar 31, 2023 5.36 Mn
Dec 31, 2022 3.65 Mn
Sep 30, 2022 4.00 Mn
Jun 30, 2022 4.48 Mn
Mar 31, 2022 3.73 Mn
Dec 31, 2021 3.92 Mn
API Access

Replimune Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=REPL&period=max&api_key=YOUR_API_KEY